v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT05252923 |
Full text link
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
lobastov_kv@hotmail.com |
Registration date
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
2022-02-23 |
Recruitment status
Last imported at : April 23, 2022, 1:30 a.m. Source : ClinicalTrials.gov |
Recruiting |
Study design
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: over 18 years old male or female documented pcr sars-cov-2 positive test covid-19 convalescence (define as at least 10 days after the onset of symptoms, no fever for at least 24 hours without the use of antipyretics and improvement of respiratory symptoms) informed consent signed clinical severity presentation of severe the disease is classified as severe if one of the following conditions is met: respiratory distress, respiratory rate ≥30/min oxygen saturation on room air at rest ≤93%. partial pressure of oxygen in arterial blood/fio2 ≤300 mm hg. or critical if one of the following conditions is met. respiratory failure and mechanical ventilation are required. shock occurs another organ dysfunction is present risk of health complication >50% according to the health risk calculator less than 14 days of hospital discharge. |
Exclusion criteria
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
concomitant use of another anticoagulant known pregnancy known hypersensitivity to sulodexide need for hospital care at screening renal insufficiency with crcl <30ml/min or continuous renal replacement therapy, hemodialysis, or peritoneal dialysis. blood platelet count < 30 000/µl other conditions that are judged to carry an increased risk of bleeding as judged by the investigator more than 30 days of clinical onset |
Number of arms
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Pirogov Russian National Research Medical University |
Inclusion age min
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
100 |
Countries
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Russia |
Type of patients
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Mild/moderate disease at enrollment |
Severity scale
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
2: Mild/moderate disease at enrollment |
Total sample size
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
30 |
primary outcome
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Serum level of soluble Thrombomodulin |
Notes
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
Phase 4 |
Arms
Last imported at : Feb. 24, 2022, 6:30 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1245, "treatment_name": "Sulodexide", "treatment_type": "Coagulation modifiers", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |